Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway
Jianpi Yiqi Busui Prescription (JYBP), a traditional Chinese medicine (TCM) formula, is used in the treatment of myasthenia gravis (MG). However, its mechanisms of action still require further clarification. In this study, an experimental autoimmune myasthenia gravis (EAMG) rat model was establishe...
Saved in:
Main Authors: | Zhuming Chen, Jing Lu, Tianying Chang, Dongmei Zhang, Yibin Zhang, Miao Liu, Tong Wu, Peng Xv, Jian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2025-02-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://bjbms.org/ojs/index.php/bjbms/article/view/11546 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab in Refractory Myasthenia Gravis – Challenges and Lessons Learnt
by: Karthika A Valaparambil, et al.
Published: (2024-12-01) -
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
Exploring the clinical significance of anti-acetylcholine receptor antibody titers, changes, and change rates in Myasthenia Gravis
by: Lijun Luo, et al.
Published: (2025-01-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01) -
Surgical Treatment of the Oroantral Fistula in a Patient with Myasthenia Gravis: Clinical Considerations and Anesthetical Management
by: Elif Betül Yıldırım, et al.
Published: (2024-04-01)